Previous studies have shown that under pathological conditions of RA, p‐p65 enhances NF‐κB activity, while p‐IκBα undergoes degradation, releasing NF‐κB to translocate into the nucleus and activate pro‐inflammatory gene expression. This evidence concerns the gene NFKB1 and rheumatoid arthritis.